Reportlinker Adds Opioids Market to 2017 – Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market

NEW YORK, May 26, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:

Opioids Market to 2017 – Steady Uptake of Oxycontin and High
Incidence Of Diseases Such As Cancer And Arthritis to Drive the
Market

http://www.reportlinker.com/p0512133/Opioids-Market-to-2017—Steady-Uptake-of-Oxycontin-and-High-Incidence-Of-Diseases-Such-As-Cancer-And-Arthritis-to-Drive-the-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Opioids Market to 2017 – Steady Uptake of Oxycontin and High
Incidence Of Diseases Such As Cancer And Arthritis to Drive the
Market

Summary

GBI Research, the leading business intelligence provider, has
released its latest research, “Opioids Market to 2017 – Steady
Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer
And Arthritis to Drive the Market”, which provides insights into
global opioids market and market forecast until 2017. The report
provides an in-depth analysis of the top seven therapeutic
indications for which often opioids are prescribed which includes
fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain,
rheumatoid arthritis pain, low back pain and post operative pain.
The report also examines the global opioids treatment usage
patterns for the covered indication. In addition, the report also
includes insights into the opioids R&D pipeline.

Report

‘/>”/>

SOURCE